Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

71.88
-0.4100-0.57%
Volume:587.81K
Turnover:42.29M
Market Cap:13.85B
PE:-17.18
High:72.64
Open:72.37
Low:71.01
Close:72.29
52wk High:81.33
52wk Low:28.33
Shares:192.71M
Float Shares:151.20M
Volume Ratio:0.26
T/O Rate:0.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1844
EPS(LYR):-2.8793
ROE:-1789.67%
ROA:-43.47%
PB:-7.17
PE(LYR):-24.96

Loading ...

Jan 21, 2026

Major Issues Report

Form 8-K - Current report
Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 29, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 29, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2025

Major Issues Report

Form 8-K - Current report
Oct 29, 2025

Major Issues Report

Form 8-K - Current report
Oct 27, 2025

Major Issues Report

Form 8-K - Current report
Oct 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities